Acthrel (Ferring Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Acthrel drug offered from Ferring Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ferring Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Corticorelin ovine triflutate |
SUBSTANCE NAME: | CORTICORELIN OVINE TRIFLUTATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1996-05-23 |
END MARKETING DATE: | 0000-00-00 |
Acthrel HUMAN PRESCRIPTION DRUG Details:
Item Description | Acthrel from Ferring Pharmaceuticals Inc. |
LABELER NAME: | Ferring Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(ug/2mL) |
START MARKETING DATE: | 1996-05-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55566-0302_4698848e-3251-49f8-bcac-614fd485c784 |
PRODUCT NDC: | 55566-0302 |
APPLICATION NUMBER: | NDA020162 |
Other CORTICORELIN OVINE TRIFLUTATE Pharmaceutical Manufacturers / Labelers: